Exploring GLP-1 Receptor Agonists: Beyond Cardiometabolic Effects
In recent years, the therapeutic landscape of metabolic and cardiovascular diseases has been revolutionized by glucagon-like peptide-1 receptor agonists (GLP-1 ...
In recent years, the therapeutic landscape of metabolic and cardiovascular diseases has been revolutionized by glucagon-like peptide-1 receptor agonists (GLP-1 ...
In a groundbreaking synthesis of clinical data, a recent umbrella review spearheaded by Kong, Zhao, Zhang, and colleagues critically assesses ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine